REPORTING FROM THE 2019
CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS ANNUAL MEETING
FRIDAY, MAY 31
On the Agenda Today
Fred Lublin Receives the 2019 June Halper Lifetime Achievement Award at Consortium of Multiple Sclerosis Centers 33rd Annual Meeting
CMSC President Michael Racke and Continuing Education Co-chair Corey Ford (right) congratulate Fred Lublin, MD (center), on his receipt of the 2019 June Halper Lifetime Achievement Award. Dr. Lublin, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center in New York City, is known for his work in refining MS diagnostic criteria and classification of MS phenotypes.Photo Credit @ThePhotoGroup
Dr. Lublin is the Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center in New York City. Dr. Lublin received his medical degree at Jefferson Medical College in Philadelphia, PA, internship and residency from Albert Einstein Medical Center and the New York Hospital, Cornell Medical Center, both in New York. As a neuroimmunologist, he has gone on to become an internationally renowned authority on the scientific and clinical aspects of MS. Dr. Lublin has served on many important committees and societies in the field of MS. He is widely recognized for his efforts to improve the classification of different presentations and phenotypes in MS, in order to better focus treatment efforts.
Along with his history of invaluable contributions to the field of MS care and research, Dr. Lublin has been extremely generous to the CMSC with his time and expertise. The CMSC is an important organization, he said, because it brings together the whole MS care team. "The CMSC has evolved to meet the expanding needs for comprehensive care in MS. The disease is complex, our therapies have gotten more complex, the needs of our patients have increased, and so this interdisciplinary approach is key to providing excellent healthcare to patients with MS."
© 2019, Consortium of Multiple Sclerosis Centers and Delaware Media Group. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or Genentech.